The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

FLUPHENAZINE IN CHRONIC REFRACTORY SCHIZOPHRENICS

Published Online:https://doi.org/10.1176/ajp.119.1.72

In light of these findings we can only conclude that fluphenazine is not of any material value over any of the other phenothiazines in the treatment of the chronic refractory schizophrenics.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.